Trimethylaminuria (TMAU) is a rare metabolic syndrome caused by the accumulation of trimethylamine in the body, causing odor emissions similar to rotten fish in affected patients. This condition is determined by both genetic and environmental factors, especially gut dysbiosis. The multifactorial nature of this syndrome makes for a complex and multi-level diagnosis. To date, many aspects of this disease are still unclear. Recent research revealed the haplotypes' role on the enzyme's catalytic activity. This could explain why patients showing only combined polymorphisms or heterozygous causative variants also manifest the TMAU phenotype. In addition, another research hypothesized that the behavioral disturbances showed by patients may be linked to gut microbiota alterations. Our review considers current knowledge about TMAU, clarifying its molecular aspects, the therapeutic approaches used to limit this condition, and the new therapies that are under study.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11726875 | PMC |
| http://dx.doi.org/10.3390/biology13120961 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Exploring Trimethylaminuria: Genetics and Molecular Mechanisms, Epidemiology, and Emerging Therapeutic Strategies.
Biology (Basel)
November 2024
Alfasigma SpA, Via Pontina, km 30,400, 00071 Rome, Italy.
Trimethylaminuria (TMAU) is a rare metabolic syndrome caused by the accumulation of trimethylamine in the body, causing odor emissions similar to rotten fish in affected patients. This condition is determined by both genetic and environmental factors, especially gut dysbiosis. The multifactorial nature of this syndrome makes for a complex and multi-level diagnosis.
View Article and Find Full Text PDFFMO3 deficiency of duck leads to decreased lipid deposition and increased antibacterial activity.
J Anim Sci Biotechnol
November 2022
College of Animal Science and Technology, China Agricultural University, Beijing, 100193, China.
Background: Most duck eggs possess a fishy odor, indicating that ducks generally exhibit impaired trimethylamine (TMA) metabolism. TMA accumulation is responsible for this unpleasant odor, and TMA metabolism plays an essential role in trimethylaminuria (TMAU), also known as fish odor syndrome. In this study, we focused on the unusual TMA metabolism mechanism in ducks, and further explored the unclear reasons leading to the debilitating TMA metabolism.
View Article and Find Full Text PDFBackground: Trimethylaminuria (TMAU) (OMIM #602079) is a rare inherited metabolic condition. TMAU is associated with decreased hepatic trimethylamine N-oxidation, which leads to an excess of the volatile trimethylamine (TMA) instead of substrate conversion to trimethylamine N-oxide (TMAO). TMA is a tertiary amine derived from the enterobacterial metabolism of precursors such as choline and phosphatidylcholine present in the diet, and is also a bacterial metabolite of TMAO, a normal constituent of saltwater fish.
View Article and Find Full Text PDFDelusions of foul body odors (often referred to as olfactory reference syndrome [ORS]) currently fall under the category of delusional disorder, somatic type (DDST), in the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV). We present the case of a 51-year-old man with no previous psychiatric history who presented with perceived foul odors that he delusionally attributed to trimethylaminuria (TMAU). TMAU is a rare metabolic disorder associated with foul body odors.
View Article and Find Full Text PDFMammalian flavin-containing monooxygenases: structure/function, genetic polymorphisms and role in drug metabolism.
Pharmacol Ther
June 2005
Department of Environmental and Molecular Toxicology and The Linus Pauling Institute, Oregon State University, USA.
Article Synopsis
- Flavin-containing monooxygenase (FMO) is an enzyme that oxidizes drugs and other compounds with nitrogen or sulfur, using NADPH and molecular oxygen in a different manner than cytochrome P450 (CYP).
- FMO has a smaller gene family in humans, does not rely on a reductase for electron transfer, and its activity is not induced by foreign substances like xenobiotics, making CYP a more significant player in drug metabolism.
- Understanding the physiological roles of FMO and its genetic variations, especially FMO3, is essential, as they can impact drug metabolism and have potential health implications like trimethylaminuria.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!